「des」の検索結果
21件:1~5件目を表示
-

for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition of TRPV1....
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -

Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
Designated quasi-drugs Mytear® HARD LENS WETTING SOLUTION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable len...
http://www.senju.co.jp/english/products/wettingsolution.html -

OTC Products, etc. | Products | SENJU Pharmaceutical
2 OTC medicines Mytear Vido マイティア美瞳 There are no eligible products. Eye-lotions for contact lenses Designated quasi-drugs Mytear HARD LENS WETTING SOLUTION マイティアハードレンズ装着液 Can not be used for soft con...
http://www.senju.co.jp/english/products/otc.html -

for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition of TRPV1....
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -

Research and Development System | Research & Development | SENJU Pharmaceutica
n improving the formulation characteristics of products under development and existing products. We design the types and quantities of excipients while considering safety to ensure that drugs can full...
http://www.senju.co.jp/english/rd/about/